Thoracic Medical Oncology - Assistant Professor of Medicine
Dana-Farber Cancer Institute - Harvard Medical School
Boston, Massachusetts, United States
Dr. Narjust Florez is originally from Venezuela, she graduated first in her medical school class at the Universidad Catolica Nordestana in the Dominican Republic. She completed her internal medicine residency at Rutgers New Jersey Medical School (selected as the most scholarly resident in the Department of Medicine in 2015 and 2016) and fellowship at the Mayo Clinic in Rochester, Minnesota, where she was Chief Fellow from 2018 -2019.
She is a thoracic medical oncologist and the Associate Director of The Cancer Care Equity Program at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. In 2022, Dr. Florez also became the first Latina to hold an Associate Editor position in Oncology as the new Associate Editor for Diversity, Equity, and Inclusion at JAMA Oncology.
Dr. Florez’s clinical interests include targeted therapy for lung cancer and the care of women and young patients with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer. Additionally, she is also the principal investigator on other notable studies, including the Fertility and Sexual Health Effects of Immune Checkpoint Inhibitors on young women with Non-small Cell Lung Cancer and Melanoma (FhINCH) Study, The Diagnostic Delays in Lung Cancer (LEAD) Study, and the Young Lung Cancer (YLC) Study, which evaluates the psychosocial needs of young patients with lung cancer.
Dr. Florez has over 115 scientific publications and her work has been published in high impact journals such as the Journal of Clinical Oncology, Nature, Cancer Cell, JAMA Oncology and Lancet Oncology.
Disclosure information not submitted.
Targeted Therapy 101—How Does it Work?
Saturday, January 25, 2025
3:54pm – 4:02pm PT